Skip to content
Optionomics

CLVT earnings analysis

10-Q · Filed November 3, 2026 · Our reading of the company's report

The latest report

Clarivate delivered an adjusted EPS beat at $0.21 versus the $0.17 consensus estimate, but continuing-operations revenue of $481.6 million missed the $508.638 million estimate. GAAP results remained pressured by a $62.2…

Read full summary

Clarivate delivered an adjusted EPS beat at $0.21 versus the $0.17 consensus estimate, but continuing-operations revenue of $481.6 million missed the $508.638 million estimate. GAAP results remained pressured by a $62.2 million goodwill impairment, producing diluted EPS of $(0.13). Management issued 2026 targets of $1.965-$1.985 billion in revenue, $0.73-$0.77 of adjusted EPS, and $320-$340 million of free cash flow, but the direction versus its previous outlook cannot be determined.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

68% Gross margin Operating margin Aug 2022 Jul 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Aug 2022 Nov 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$-0.13

What stood out

  • Adjusted EPS beat estimates

    Adjusted diluted EPS was $0.21, above the $0.17 consensus estimate, despite reported continuing-operations revenue of $481.6 million.

  • 2026 outlook provided

    Management provided a 2026 outlook of $1.965-$1.985 billion of revenue and $0.73-$0.77 of adjusted diluted EPS, with free cash flow expected at $320-$340 million.

  • Controls remained effective

    Disclosure controls were assessed as effective as of September 30, 2026, and management reported no changes during the quarter that materially affected internal control over financial reporting.

What to watch

  • Goodwill impairment drove GAAP loss

    A $62.2 million goodwill impairment contributed to a reported diluted EPS loss of $(0.13), indicating continued GAAP earnings pressure despite the $0.21 adjusted EPS result.

  • Revenue materially missed consensus

    Continuing-operations revenue of $481.6 million was below the $508.638 million consensus estimate, a shortfall of approximately $27.0 million.

  • Insider selling plan

    The filing reports no material changes to prior risk factors, but a trading plan permits the sale of up to 254,558 ordinary shares by the President of Academia & Government through December 7, 2026.

  • Board composition change

    A director resignation is effective December 31, 2026. The director stated that the resignation was not due to disagreement with the company, management, board, or any committee.

Management's outlook

Updated 2026 outlook excludes discontinued operations and calls for revenue of $1.965-$1.985 billion, adjusted diluted EPS of $0.73-$0.77, and free cash flow of $320-$340 million. The filing/release does not provide enough prior-outlook detail to determine whether the outlook was raised or lowered.

Earlier filings 4

10-Q · July 29, 2026

Clarivate’s Q2 revenue declined 5.5% year over year to $587.3M, with all segments lower and transactional revenue down 30.1%. Cost discipline lifted gross margin to 68.4% and adjusted EBITDA margin held at 42.1%, but a…

10-Q · April 29, 2026

Clarivate's Q1 2026 results showed a slight revenue decline of 1.4% year-over-year, totaling $585.5 million, while net losses improved to $40.2 million from $103.9 million in the prior year. Despite ongoing…

10-K · February 24, 2026

Clarivate positions itself as a leading provider of AI-enabled, subscription and re-occurring intelligence solutions across Academia & Government, Intellectual Property, and Life Sciences & Healthcare, serving more than…

10-Q · July 30, 2025

Clarivate reported revenue of $621.4M for Q2 (June 30, 2025), a sequential increase from ~$594.0M but down vs. Q2 2024. Operating performance improved materially — income from operations was $6.9M vs an operating loss…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.

See every CLVT trade live.

The free pages stop at the last full session. Trader shows every trade as it prints.

Start tracking No card needed.